Buy Madras Cement, tgt Rs 4000: Sharekhan

Published on Thu, Jul 03, 2008 at 10:23 |  Source : Moneycontrol.com

Updated at Thu, Jul 03, 2008 at 10:28  

7120 Investors following Madras Cements. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

Sharekhan research has maintianed buy rating on Madras Cement with target price of Rs 4000 in its June 02, 2008 report. "Going forward, the top line growth of the company will be driven primarily by the volume growth on the back of capacity additions being carried out by the company. However, we have revised our profit estimates for FY2009 downwards to factor in the higher input cost, and now expect the company's net profit to grow at 5.3% yoy. We have also introduced FY2010 earning estimates in this note and expect the company's net profit to grow 16.6% yoy in FY2010. At the current market price of Rs2,712, the share trades at 7.5x and 6.4x its FY2009 and FY2010 earnings respectively and an enterprise value (EV)/EBIDTA of 5.7x and 4x for FY2009 and FY2010 respectively. We maintain our Buy recommendation on the stock with a revised price target of Rs 4,000" according to Sharekhan report. 

 

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

  

More on Moneycontrol

Trending News

Business News

Apple rushing to finalize apps for iPad 3 announcement
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com